Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGF
US20260297657A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name REGENERON PHARMA [US].
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260297657A1 · Application publication visible